JP2014524747A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524747A5
JP2014524747A5 JP2014520591A JP2014520591A JP2014524747A5 JP 2014524747 A5 JP2014524747 A5 JP 2014524747A5 JP 2014520591 A JP2014520591 A JP 2014520591A JP 2014520591 A JP2014520591 A JP 2014520591A JP 2014524747 A5 JP2014524747 A5 JP 2014524747A5
Authority
JP
Japan
Prior art keywords
concentration
factor
collection
detergent
ctab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014520591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524747A (ja
JP6275641B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/063045 external-priority patent/WO2013010797A1/en
Publication of JP2014524747A publication Critical patent/JP2014524747A/ja
Publication of JP2014524747A5 publication Critical patent/JP2014524747A5/ja
Application granted granted Critical
Publication of JP6275641B2 publication Critical patent/JP6275641B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014520591A 2011-07-20 2012-07-04 ウイルス抗原およびワクチンの製造方法 Expired - Fee Related JP6275641B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
EP11174660 2011-07-20
US61/509,630 2011-07-20
EP11174660.8 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Publications (3)

Publication Number Publication Date
JP2014524747A JP2014524747A (ja) 2014-09-25
JP2014524747A5 true JP2014524747A5 (enExample) 2016-11-04
JP6275641B2 JP6275641B2 (ja) 2018-02-07

Family

ID=45094875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520591A Expired - Fee Related JP6275641B2 (ja) 2011-07-20 2012-07-04 ウイルス抗原およびワクチンの製造方法

Country Status (12)

Country Link
EP (1) EP2734619B1 (enExample)
JP (1) JP6275641B2 (enExample)
KR (2) KR20160096215A (enExample)
CN (1) CN103827296B (enExample)
AU (1) AU2012286098C1 (enExample)
BR (1) BR112014001049A2 (enExample)
CA (1) CA2841604C (enExample)
ES (1) ES2653197T3 (enExample)
MX (1) MX2014000753A (enExample)
RU (1) RU2565827C2 (enExample)
TW (1) TW201311896A (enExample)
WO (1) WO2013010797A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524563A (zh) * 2014-12-12 2015-04-22 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
EP3728287B1 (en) 2017-12-19 2024-04-10 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
AU2019286406B2 (en) 2018-06-12 2023-04-13 Kbio Holdings Limited Virus and antigen purification and conjugation
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
CA3104392A1 (en) * 2018-07-04 2020-01-09 Probiogen Ag Method for purifying an enveloped virus
EP3880806A1 (en) 2018-11-15 2021-09-22 Bayer HealthCare, LLC Viral inactivation methods for continuous manufacturing of antibodies
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
BR112022008711A2 (pt) * 2019-11-07 2022-07-19 Seqirus Uk Ltd Métodos para produzir uma vacina viral e reduzir o tamanho da partícula viral
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
AU2021264292A1 (en) * 2020-04-29 2022-12-08 Sk Bioscience Co., Ltd. Influenza virus production method using single-use culture process system and rapid confirmation test of influenza virus antigen purification condition
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US7262045B2 (en) * 2003-02-25 2007-08-28 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
SG10201404101RA (en) * 2007-08-28 2014-09-26 Baxter Int Method For Producing Viral Vaccines
EP2268309B1 (en) * 2008-03-18 2015-01-21 Novartis AG Improvements in preparation of influenza virus vaccine antigens
KR20110074564A (ko) * 2008-09-24 2011-06-30 메디뮨 엘엘씨 세포 배양, 바이러스 증식 및 바이러스 정제를 위한 방법
KR20110074563A (ko) * 2008-09-24 2011-06-30 메디뮨 엘엘씨 바이러스의 정제 방법
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Similar Documents

Publication Publication Date Title
JP5745717B2 (ja) ウイルス精製のための連続超遠心分離用の糖溶液の処方
Weigel et al. A flow-through chromatography process for influenza A and B virus purification
Rupar et al. Fast purification of the filamentous Potato virus Y using monolithic chromatographic supports
Kim et al. One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae
JP2018511347A (ja) ウイルス用無菌精製プロセス
CN102286460A (zh) 一种改进ctab法提取杏鲍菇中的dna
JP2007523883A5 (enExample)
US11697800B2 (en) Method for the separation of virus compositions including depletion and purification thereof
CN105612250A (zh) 经处理的滤器
KR101942626B1 (ko) 노다바이러스 캡시드 단백질의 정제 수율 증가 방법
JP6507561B2 (ja) 米に含まれるタンパク質の回収方法
EP2699248B1 (fr) Procédé de préparation d'un produit plasmatique déplété en un ou plusieurs facteurs thrombogenes
CN107164334B (zh) 一种猪圆环病毒繁殖培养基及其应用
JP6467139B2 (ja) 狂犬病ウイルスの複製促進・増強方法
Wang et al. A primary study on partial purification of lysozyme from chicken egg white using foam separation method
KR20150057120A (ko) 간염 바이러스로부터 핵산을 추출하기 위한 세포 용해 조성물
JP2025092571A (ja) 低減した粒度を有するウイルスワクチンを生成するための組成物および方法
CN104130317B (zh) 一种重组戊型肝炎疫苗p179抗原的纯化方法
JP2023500873A5 (enExample)
JPH0330691A (ja) 形質転換酵母細胞からb型肝炎表面抗原を単離する方法
CN115651917A (zh) Ca16病毒灭活液的纯化方法及ca16病毒灭活原液的制备方法
JP4617464B2 (ja) スパイロソームの分離精製方法
HK1138318B (en) Formulation of sugar solutions for continuous ultracentrifugation for virus purification